Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lipoatrophic Diabetes Mellitus”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT00286442
What this trial is testing

Efficacy and Safety of Alogliptin Combined With Metformin in Participants With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 527
Large-scale testing (Phase 3)Study completedNCT00225264
What this trial is testing

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

Who this might be right for
Diabetes Mellitus
Takeda 458
Large-scale testing (Phase 3)Active Not RecruitingNCT02262832
What this trial is testing

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

Who this might be right for
LipodystrophyDiabetesHyperlipidemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Large-scale testing (Phase 3)Study completedNCT00225277
What this trial is testing

Efficacy Study of Pioglitazone Compared to Glimepiride on Coronary Atherosclerotic Disease Progression in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 547
Not applicableStudy completedNCT00449553
What this trial is testing

Observational Study to Assess Glycosylated Hemoglobin Changes After 6 Months of Treatment With Pioglitazone.

Who this might be right for
Diabetes Mellitus
Takeda 326
Large-scale testing (Phase 3)Ended earlyNCT00762112
What this trial is testing

Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 316
Post-approval studies (Phase 4)Study completedNCT00754403
What this trial is testing

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 312
Large-scale testing (Phase 3)Ended earlyNCT00762957
What this trial is testing

Safety and Efficacy of TAK-559 in Combination With Metformin in Patients With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 15
Large-scale testing (Phase 3)Study completedNCT00727857
What this trial is testing

Efficacy and Safety of Pioglitazone and Metformin Combination Therapy in Treating Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 600
Post-approval studies (Phase 4)Study completedNCT00708175
What this trial is testing

Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

Who this might be right for
Bone Metabolism
Takeda 156
Large-scale testing (Phase 3)Study completedNCT00286468
What this trial is testing

Study of Alogliptin Combined With Sulfonylurea in Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 500
Large-scale testing (Phase 3)Ended earlyNCT00762190
What this trial is testing

Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 348
Large-scale testing (Phase 3)Study completedNCT00707993
What this trial is testing

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Who this might be right for
Diabetes Mellitus
Takeda 441
Large-scale testing (Phase 3)Study completedNCT00763022
What this trial is testing

Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 302
Large-scale testing (Phase 3)Active Not RecruitingNCT06548100
What this trial is testing

The Safety of Mibavademab in Pediatric and Adult Participants Switching From Metreleptin to Mibavademab for the Treatment of Generalized Lipodystrophy (GLD)

Who this might be right for
Generalized Lipodystrophy
Regeneron Pharmaceuticals 9
Large-scale testing (Phase 3)Ended earlyNCT00759720
What this trial is testing

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

Who this might be right for
Diabetes Mellitus
Takeda 447
Testing effectiveness (Phase 2)Ended earlyNCT00722917
What this trial is testing

Efficacy and Safety of TAK-379 in Adult Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Takeda 323
Large-scale testing (Phase 3)Study completedNCT00772174
What this trial is testing

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus
Takeda 418
Large-scale testing (Phase 3)Looking for participantsNCT06502990
What this trial is testing

Open-label Study to Evaluate Metreleptin in Children Under 6 Years of Age With Generalised Lipodystrophy

Who this might be right for
Generalized Lipodystrophy
Amryt Pharma 15
Testing effectiveness (Phase 2)Study completedNCT00676260
What this trial is testing

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Who this might be right for
Diabetes Mellitus
Takeda 29
Load More Results